![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4709 | (2006.01) |
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3432883 |
(13) | Kind of document | T |
(96) | European patent application number | 18708563.4 |
Date of filing the European patent application | 2018-02-21 | |
(97) | Date of publication of the European application | 2019-01-30 |
(45) | Date of publication and mention of the grant of the patent | 2021-07-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2018/018989 |
Date | 2018-02-21 |
(87) | Number | WO 2018/156609 |
Date | 2018-08-30 |
(30) | Number | Date | Country code |
201762461602 P | 2017-02-21 | US | |
201762507749 P | 2017-05-17 | US | |
201762519819 P | 2017-06-14 | US | |
201715820157 | 2017-11-21 | US | |
201715820012 | 2017-11-21 | US | |
201762596653 P | 2017-12-08 | US |
(72) |
GUALBERTO, Antonio , US
SCHOLZ, Catherine, Rose , US
|
(73) |
Kura Oncology, Inc. ,
12730 High Bluff Drive, Suite 400, San Diego, CA 92130,
US
|
(54) | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS |
METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS |